United States

People: Bristol-Myers Squibb Co (BMY)

BMY on New York Consolidated

24 Mar 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sato, Vicki 

Dr. Vicki L. Sato, Ph.D., is Independent Director of Bristol-Myers Squibb Company. She has served as a professor of management practice at the Harvard Business School since July 2005. From July 2005 to October 2014 she served as professor of the practice of molecular and cell biology at Harvard University. In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal, and finance. Dr. Sato also served as Chief Scientific Officer, Senior Vice President of Research and Development, and Chair of the Scientific Advisory Board at Vertex before being named President in 2000.

Basic Compensation

Total Annual Compensation, USD 130,000
Restricted Stock Awards, USD 160,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 290,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --